Centre Val d'Aurelle Becomes First Hospital in France to Deliver Advanced Radiotherapy Treatments Using TrueBeam

Leading Cancer Center in Montpellier Commence Treatments on First of Three TrueBeam Devices

MONTPELLIER, France, Dec. 6, 2011 - A 19-year-old brain tumor patient has become the first person in France to be treated using the highly advanced TrueBeam(TM) radiotherapy treatment system from Varian Medical Systems (NYSE:VAR). The male patient's cerebral glioblastoma was treated quickly and efficiently at the Cancer Research Center of Languedoc-Roussillon at the Centre Val d'Aurelle, Montpellier. Following this initial treatment, dozens more patients have been treated using the newly-deployed device, one of three acquired by the hospital.

"We believe that the system's dose delivery speed and its unique ability to image the patient during the treatment will bring considerable benefits for our patients," says Professor Jean-Bernard Dubois, head of radiotherapy. "With TrueBeam we are able to image the tumor during the treatment and adapt the treatment delivery in 'real-time', which helps to better target the tumor and limit damage to surrounding healthy organs."

Dr. Pascal Fenoglietto, head of research of the hospital's physics department, said the TrueBeam, which is now treating 20 patients a day, can deliver dose up to six times more quickly than other treatment devices, enabling much greater throughput at the busy hospital. "We considered other systems but it was clear that TrueBeam can achieve the same treatment quality in a dramatically shorter time," he said. The hospital is currently installing two more TrueBeam devices, one of them a TrueBeam STx which is especially configured for stereotactic radiosurgical treatments.

Designed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, the TrueBeam platform for image-guided radiotherapy and radiosurgery is a fully-integrated radiotherapy system designed from the ground up to treat a moving target with speed and precision. It features a High Intensity Mode-one of six dose levels available to doctors with the TrueBeam platform-for customizing dose delivery based on a patient's specific tumor characteristics.

The Centre Val d'Aurelle, which delivers radiotherapy treatments for 2,000 new cancer patients each year, was one of the first hospitals in France to introduce IMRT (intensity modulated radiotherapy) ten years ago and has now become the first to offer TrueBeam treatments.

"We intend to use our TrueBeam devices to treat all forms of cancer, especially those that involve tumor motion, and it enables us to use more complex techniques for the benefit of our patients," said Professor David Azria, head of radiobiology and translational research. "We see TrueBeam as the future development platform in linear accelerators and we wish to be up-to-date for the next ten years."

Designed to be a versatile platform, a TrueBeam system can be used for all forms of advanced external-beam radiotherapy including image-guided radiotherapy and radiosurgery (IGRT and IGRS), intensity-modulated radiotherapy (IMRT), stereotactic radiotherapy and radiosurgery (SBRT/SRS) and RapidArc® radiotherapy.

The first treatment at Centre Val d'Aurelle was a RapidArc® treatment, an approach used at the hospital since 2008. RapidArc enables image-guided IMRT treatments to be delivered in a continuous rotation of the machine around the patient, rather than using multiple discreet beam delivery angles, making it possible to complete treatments quickly and efficiently in a matter of minutes.

Youssef Rihane, Varian's France regional director, said, "This hospital has a long history of pioneering radiotherapy treatments, having treated 2,000 patients with IMRT since 2001 including 1,000 with RapidArc®, and we are delighted to be working with them to bring state-of-the-art TrueBeam radiotherapy and radiosurgery to this region."

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit www.varian.com or follow us on Twitter.

SOURCE Varian Medical Systems

More from Agricultural & Farming Products

All Topics